Pure Global

Choice of Inhalation Device - Trial NCT05264441

Access comprehensive clinical trial information for NCT05264441 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitair Ziekenhuis Brussel and is currently Not yet recruiting. The study focuses on Asthma,COPD. Target enrollment is 140 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05264441
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05264441
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Choice of Inhalation Device
Choice of Inhalation Device in Asthma and COPD Patients

Study Focus

Asthma,COPD

In-Check DIAL G16

Interventional

device

Sponsor & Location

Universitair Ziekenhuis Brussel

Timeline & Enrollment

N/A

Apr 01, 2022

Jun 01, 2023

140 participants

Primary Outcome

Proportion of patients with device mismatch

Summary

In this study, asthma and COPD patients will be invited to participate after the consultation
 with their pulmonologist.
 
 The intervention consists of three steps. The first step is to perform a deep inspiration.
 The second step is to demonstrate the correct use of a pMDI. The third step is to perform a
 strong inspiration into the In-Check Dial device over 5 different resistances.

ICD-10 Classifications

Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Other chronic obstructive pulmonary disease

Data Source

ClinicalTrials.gov

NCT05264441

Device Trial